MedTrace Logo

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT01868126 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2018-04-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and efficacy of four concentrations of DE-117 ophthalmic solution.

Conditions

  • Open-angle Glaucoma or Ocular Hypertension

Interventions

DRUG

DE-117 ophthalmic solution

DRUG

latanoprost ophthalmic solution

OTHER

Placebo

Sponsors & Collaborators

  • Santen Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-08-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01868126 on ClinicalTrials.gov